FLGT
FLGT
NASDAQ · Health Care

Fulgent Genetics Inc

$16.72
+0.38 (+2.33%)
As of Mar 25, 2:26 PM ET ·
Financial Highlights (FY 2026)
Revenue
287.16M
Net Income
-43,263,183
Gross Margin
37.8%
Profit Margin
-15.1%
Rev Growth
-34.2%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 37.8% 37.8% 39.4% 39.4%
Operating Margin -29.6% -26.7% 19.5% 19.5%
Profit Margin -15.1% -14.3% 13.5% 13.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 287.16M 436.09M 242.23M 275.80M
Gross Profit 108.61M 164.93M 95.53M 108.77M
Operating Income -85,086,515 -116,291,364 47.17M 53.86M
Net Income -43,263,183 -59,129,635 32.57M 36.27M
Gross Margin 37.8% 37.8% 39.4% 39.4%
Operating Margin -29.6% -26.7% 19.5% 19.5%
Profit Margin -15.1% -14.3% 13.5% 13.2%
Rev Growth -34.2% -34.2% -1.5% -4.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 709.8K 709.8K 257.54M 237.86M
Total Equity 221.81M 221.81M 521.51M 552.15M
D/E Ratio 0.00 0.00 0.49 0.43
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -76,446,428 -110,287,177 59.74M 74.06M
Free Cash Flow 22.63M 30.51M